Jennings M T, Jennings D L, Ebrahim S A, Johnson M D, Turc-Carel C, Philip T, Philip I, Lapras C, Shapiro J R
Vanderbilt University Medical Center, Nashville, Tennessee 37232-3375.
Eur J Cancer. 1992;28A(4-5):762-6. doi: 10.1016/0959-8049(92)90111-e.
Monoclonal antibody (Mab) mediated immunotherapy of brain tumours requires the identification of tumour-restricted cell surface antigens. We have characterised four primitive neuroectodermal tumours, which included pineoblastoma, medulloblastoma and ependymoblastoma cultures, that demonstrated in vitro evidence of malignant behaviour (anchorage-independent growth and nu/nu xenograft tumour formation). The cytogenetic findings ranged from normal G-banded and Q-banded karyotypes through mixed near-diploid/hyperdiploid. These cultures resembled the cell surface immunophenotypic spectrum of malignant gliomas. They were distinguished from normal glia in vitro by the expression of restricted fetal mesenchymal, neuronal, myoblastic, melanocytic, epidermal, chondrocytic, lymphoid and epithelial antigens. Certain antigens appeared sufficiently represented among central nervous system (CNS) neoplasms to afford potential targets for Mab-mediated immunotherapy.
单克隆抗体(Mab)介导的脑肿瘤免疫疗法需要鉴定肿瘤限制性细胞表面抗原。我们已对四种原始神经外胚层肿瘤进行了特征描述,其中包括松果体母细胞瘤、髓母细胞瘤和室管膜母细胞瘤培养物,这些培养物在体外显示出恶性行为的证据(不依赖贴壁生长和裸鼠异种移植瘤形成)。细胞遗传学结果从正常的G带和Q带核型到混合的近二倍体/超二倍体不等。这些培养物类似于恶性胶质瘤的细胞表面免疫表型谱。它们在体外通过表达限制性胎儿间充质、神经元、成肌细胞、黑素细胞、表皮、软骨细胞、淋巴细胞和上皮抗原与正常神经胶质细胞区分开来。某些抗原在中枢神经系统(CNS)肿瘤中似乎有足够的表达,可为Mab介导的免疫疗法提供潜在靶点。